News

Printer Friendly Version View printer-friendly version
<< Back
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

BOULDER, Colo., Jan. 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   

Event:

Annual J.P. Morgan Healthcare Conference

Presenter:

Ron Squarer, Chief Executive Officer, Array BioPharma

Date:

Wednesday, January 11, 2017

Time:

8:30 a.m. Pacific Time

Location:

Westin St. Francis Hotel, San Francisco

Webcast:

http://jpmorgan.metameetings.com/confbook/healthcare17/directlink?p=22698

 

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Five registration studies are currently advancing related to three cancer drugs. These programs include binimetinib (MEK162), encorafenib (LGX818) and selumetinib (AstraZeneca).

CONTACT:

Tricia Haugeto


Array BioPharma Inc.


303-386-1193


thaugeto@arraybiopharma.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-annual-jp-morgan-healthcare-conference-300377960.html

SOURCE Array BioPharma